Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome

Atherosclerosis

Volumn 237, Issue 2, 2014, Pages 754-759

  Rath, Dominik ^a   Chatterjee, Madhumita ^a   Müller, Iris ^a   Müller, Karin ^a   Böckmann, Corinna ^a   Droppa, Michal ^a   Stimpfle, Fabian ^a   Karathanos, Athanasios ^a   Borst, Oliver ^a   Seizer, Peter ^a   Langer, Harald ^a   Schwab, Matthias ^b,c   Gawaz, Meinrad ^a   Geisler, Tobias ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Acute coronary syndrome; Coronary artery disease; Platelets; Transforming growth factor beta 1

Indexed keywords

C REACTIVE PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVENT FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HYPERLIPOPROTEINEMIA; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THROMBOCYTE;

EID: 84910682417     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.10.021     Document Type: Article

References (33)

1. Dobaczewski M., Chen W., Frangogiannis N.G. Transforming growth factor (TGF)-β signaling in cardiac remodelling. J.Mol. Cell. Cardiol. 2011, 51:600-606.
2. Bujak M., Frangogiannis N.G. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74(2):184-195.
3. Schiller M., Javelaud D., Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J.Dermatol. Sci. 2004, 35:83-92.
4. Toma I., McCaffrey T.A. Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects. Cell Tissue Res. 2012, 347:155-175.
5. Ahamed J., Burg N., Yoshinaga K., Janczak C.A., Rifkin D.B., Coller B.S. Invitro and invivo evidence for shear-induced activation of latent transforming growth factor-beta1. Blood 2008, 112:3650-3660.
6. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor-beta in human platelets: identification of a major storage site, purification, and characterization. J.Biol. Chem. 1983, 258:7155-7160.
7. Rosenkranz S., Flesch M., Amann K., Haeuseler C., Kilter H., Seeland U., et al. Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am. J. Physiol. Heart Circ. Physiol. 2002, 283:1253-1262.
8. Brooks W.W., Conrad C.H. Myocardial fibrosis in transforming growth factor beta(1) heterozygous mice. J.Mol. Cell. Cardiol. 2000, 32:187-195.
9. Meyer A., Wang W., Qu J., Croft L., Degen J.L., Coller B.S., Ahamed J. Platelet TGF-b1 contributions to plasma TGF-b1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood 2012, 119:1064-1074.
10. Petrov V.V., Fagard R.H., Lijnen P.J. Stimulation of collagen production by transforming growth factor-1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 2002, 39:258-263.
11. Weber K.T. Fibrosis and hypertensive heart disease. Curr. Opin. Cardiol. 2000, 15:264-272.
12. Petrov V.V., Fagard R.H., Lijnen P.J. Transforming growth factor-1 induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. JRAAS 2000, 1:342-352.
13. Eghbali M., Tomek R., Woods C., Bhambi B. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor-1. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:795-799.
14. ICH Harmonised Tripartite Guideline Guideline for good clinical practice. J.Postgrad. Med. 2001, 47:45-50. 121-130, 199-203.
15. Third universal definition of myocardial infarction. Eur. Heart J. 2012, 33:2551-2567.
16. Schiller N.B., Shah P.N., Crawford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J.Am. Soc. Echocardiogr. 1989, 2:258-267.
17. Machin D., Campbell M.J., Fayers P.M., Pinol A. Sample Size Tablesfor Clinical Studies 1996, Blackwell Publications, Oxford.
18. Box G.E.P., Cox D.R. An analysis of transformations. J.R. Stat. Soc. Ser. B 1964, 26:211-252.
19. Landskron G., De la Fuente M., Thuwajit P., Thuwajit C., Hermoso M.A. Chronic inflammation and cytokines in the tumor microenvironment. J.Immunol. Res. 2014, 2014:149185. Epub 2014 May 13. 10.1155/2014/149185.
20. Wang X.L., Liu S.X., Wilcken D.E. Circulating transforming growth factor beta 1 and coronary artery disease. Cardiovasc. Res. 1997, 34:404-410.
21. Fan K., Ruan Q., Sensenbrenner L., Chen B. Transforming growth factor-beta 1 bifunctionally regulates murine macrophage proliferation. Blood 1992, 79:1679-1685.
22. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 1997, 8:21-43.
23. Parker T.G., Packer S.E., Schneider M.D. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J.Clin. Invest. 1990, 85:507-514.
24. Ikeuchi M., Tsutsui H., Shiomi T., Matsusaka H., Matsushima S., Wen J., Kubota T., Takeshita A. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction. Cardiovasc. Res. 2004, 64:526-535.
25. Okada H., Takemura G., Kosai K., Li Y., Takahashi T., Esaki M., Yuge K., Miyata S., Maruyama R., Mikami A., Minatoguchi S., Fujiwara T., Fujiwara H. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 2005, 111:2430-2437.
26. Devaux Y., Bousquenaud M., Rodius S., Marie P.Y., Maskali F., Zhang L., Azuaje F., Wagner D.R. Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction. BMC Med. Genomics 2011, 4:83. 10.1186/1755-8794-4-83.
27. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P.L., Kühl U., Schlutheiss H.P. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 1999, 99:2750-2756.
28. Li R.K., Li G., Mickle D.A., Weisel R.D., Merante F., Luss H., Rao V., Christakis G.T., Williams W.G. Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation 1997, 96:874-881.
29. Fielitz J., Hein S., Mitrovic V., Pregla R., Zurbrugg H.R., Warnecke C., Schaper J., Fleck E., Regitz-Zagrosek V. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J.Am. Coll. Cardiol. 2001, 37:1443-1449.
30. Alcock R.F.1, Yong A.S., Ng A.C., Chow V., Cheruvu C., Aliprandi-Costa B., Lowe H.C., Kritharides L., Brieger D.B. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort. Int. J. Cardiol. 2013, 167(4):1343-1346.
31. Siller-Matula J.M., Lang I.M., Neunteufl T., Kozinski M., Maurer G., Linkowska K., Grzybowski T., Kubica J., Jilma B. Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention. PLoS One 2014 Jul 22, 9(7):e102701.
32. Geisler T., Langer H., Wydymus M., Göhring K., Zürn C., Bigalke B., Stellos K., May A.E., Gawaz M. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur. Heart J. 2006, 27(20):2420-2425.
33. Geisler T., Zürn C., Simonenko R., Rapin M., Kraibooj H., Kilias A., Bigalke B., Stellos K., Schwab M., May A.E., Herdeg C., Gawaz M. Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions. Eur. Heart J. 2010, 31(1):59-66.